Table 1.
Baseline Characteristics Comparing Cumulated Cases and Controls at all Three Centersa
| Variable | Cases (n=240) | Controls (n=457) | P |
|---|---|---|---|
| Age, years | 55.1±10.5 | 55.3±10.0 | .78 |
| Males | 181 (75.4) | 339 (74.3) | .72 |
| Whites | 182 (75.8) | 350 (76.6) | .97 |
| Blacks | 19 (7.9) | 34 (7.4) | |
| Hispanics | 39 (16.3) | 73 (16) | |
| AB useb | 90 (37.5) | 97 (21.2) | <0.001 |
| PPI useb | 110 (45.8) | 172 (37.6) | .07 |
| Hospitalizationb | 131 (54.6) | 94 (20.6) | <0.001 |
| MELD ≤0 | 19 (7.9) | 156 (34.1) | <0.001 |
| MELD 11-20 | 123 (51.3) | 271 (59.3) | |
| MELD 21-30 | 70 (29.2) | 28 (6.1) | |
| MELD >30 | 28 (11.7) | 2 (0.4) |
Values shown are n (%) unless otherwise stated.
a
AB = antibiotic; MELD = model for end-stage liver disease score; PPI = proton pump inhibitor.
b
Within previous 90 days before index admission.